Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electrophysiological Predictor of SSRI Response in Veterans With PTSD
NCT04183205Phase 4Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Sep 2019
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sertraline in post-traumatic stress disorder (PTSD), major depressive disorder (MDD), sponsored by VA Office of Research & Development. Started Sep 2019; status: terminated.
02
Drugs
sertraline
03
Conditions
post-traumatic stress disorder (PTSD)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04183205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04183205.